IOVANCE BIOTHERAPEUTICS, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- IOVANCE BIOTHERAPEUTICS, INC. stock issued during period, value, issued for services for the quarter ending 2014-12-31 was $430.06K.
- IOVANCE BIOTHERAPEUTICS, INC. stock issued during period, value, issued for services for the quarter ending 2014-09-30 was $384.18K.
- IOVANCE BIOTHERAPEUTICS, INC. stock issued during period, value, issued for services for fiscal 2015 was $1.77M, a 41.12% increase from fiscal 2014.
- IOVANCE BIOTHERAPEUTICS, INC. stock issued during period, value, issued for services for fiscal 2014 was $1.25M, a 358.03% increase from fiscal 2013.
- IOVANCE BIOTHERAPEUTICS, INC. stock issued during period, value, issued for services for fiscal 2013 was $274.00K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2015-12-31 | $1.77M 10-K · filed 2018-03-12 | |
| 2014-12-31 | $430.06K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $1.25M 10-K · filed 2017-03-09 |
| 2014-09-30 | $384.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | |
| 2013-12-31 | $274.00K 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |